Brian T Steffen1, Daniel Duprez2, Moyses Szklo3, Weihua Guan4, Michael Y Tsai5. 1. Department of Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, MN, USA. 2. Department of Medicine, University of Minnesota, Minneapolis, MN, USA. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 4. Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN, USA. 5. Department of Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, MN, USA. Electronic address: tsaix001@umn.edu.
Abstract
BACKGROUND: Limited evidence has suggested that circulating levels of the omega-9 fatty acid, oleic acid, may be related to greater risks of adverse cardiovascular outcomes. OBJECTIVE: We aimed to determine whether plasma oleic acid may be independently associated with clinical and subclinical cardiovascular disease (CVD) and all-cause mortality in a large multiethnic cohort. METHODS: Plasma fatty acids were measured by gas chromatography-flame ionization in 6568 participants of the Multi-Ethnic Study of Atherosclerosis. The presence of coronary artery calcium (CAC) and aortic valve calcification (AVC) was determined by computed tomography, and carotid plaque was assessed by ultrasound. Incident CVD was defined as myocardial infarction, fatal coronary heart disease, resuscitated cardiac arrest, stroke, or stroke death. Heart failure (HF) was adjudicated from clinical records. Relative risk regression estimated plasma oleic acid-related rate ratios for prevalent CAC, AVC, and carotid plaque. Cox regression estimated hazard ratios (HRs) for CVD, HF, and all-cause mortality over a median 13-year follow-up. RESULTS: Individuals in top quartiles of oleic acid showed greater rate ratios of CAC, AVC, and carotid plaque (all P < .001), but associations were rendered nonsignificant after adjustment for other risk factors. By contrast, those in top quartiles of plasma oleic acid showed significantly greater risks of incident HF (HR: 2.03; P < .001), CVD (HR: 1.41; P = .008), and all-cause mortality (HR: 1.55; P < .001) than those in referent quartiles independent of typical risk factors as well as plasma omega-3 fatty acid levels. CONCLUSIONS: Plasma oleic acid appears to be a risk factor for CVD events and all-cause mortality independent of typical risk factors and plasma omega-3 fatty acids. Additional studies are warranted for confirmation and to further examine whether plasma oleic acid directly contributes to, or serves as a marker of, disease pathogenesis. These findings should not be extrapolated to dietary oleic acid intake.
BACKGROUND: Limited evidence has suggested that circulating levels of the omega-9 fatty acid, oleic acid, may be related to greater risks of adverse cardiovascular outcomes. OBJECTIVE: We aimed to determine whether plasma oleic acid may be independently associated with clinical and subclinical cardiovascular disease (CVD) and all-cause mortality in a large multiethnic cohort. METHODS: Plasma fatty acids were measured by gas chromatography-flame ionization in 6568 participants of the Multi-Ethnic Study of Atherosclerosis. The presence of coronary artery calcium (CAC) and aortic valve calcification (AVC) was determined by computed tomography, and carotid plaque was assessed by ultrasound. Incident CVD was defined as myocardial infarction, fatal coronary heart disease, resuscitated cardiac arrest, stroke, or stroke death. Heart failure (HF) was adjudicated from clinical records. Relative risk regression estimated plasma oleic acid-related rate ratios for prevalent CAC, AVC, and carotid plaque. Cox regression estimated hazard ratios (HRs) for CVD, HF, and all-cause mortality over a median 13-year follow-up. RESULTS: Individuals in top quartiles of oleic acid showed greater rate ratios of CAC, AVC, and carotid plaque (all P < .001), but associations were rendered nonsignificant after adjustment for other risk factors. By contrast, those in top quartiles of plasma oleic acid showed significantly greater risks of incident HF (HR: 2.03; P < .001), CVD (HR: 1.41; P = .008), and all-cause mortality (HR: 1.55; P < .001) than those in referent quartiles independent of typical risk factors as well as plasma omega-3 fatty acid levels. CONCLUSIONS: Plasma oleic acid appears to be a risk factor for CVD events and all-cause mortality independent of typical risk factors and plasma omega-3 fatty acids. Additional studies are warranted for confirmation and to further examine whether plasma oleic acid directly contributes to, or serves as a marker of, disease pathogenesis. These findings should not be extrapolated to dietary oleic acid intake.
Authors: Jason H Y Wu; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Bruce M Psaty; David S Siscovick; Dariush Mozaffarian Journal: Circulation Date: 2014-08-14 Impact factor: 29.690
Authors: Marcia C de Oliveira Otto; Dariush Mozaffarian; Daan Kromhout; Alain G Bertoni; Christopher T Sibley; David R Jacobs; Jennifer A Nettleton Journal: Am J Clin Nutr Date: 2012-07-03 Impact factor: 7.045
Authors: James M Ntambi; Makoto Miyazaki; Jonathan P Stoehr; Hong Lan; Christina M Kendziorski; Brian S Yandell; Yang Song; Paul Cohen; Jeffrey M Friedman; Alan D Attie Journal: Proc Natl Acad Sci U S A Date: 2002-08-12 Impact factor: 11.205
Authors: Nirupa R Matthan; Esther M Ooi; Linda Van Horn; Marian L Neuhouser; Richard Woodman; Alice H Lichtenstein Journal: J Am Heart Assoc Date: 2014-08-13 Impact factor: 5.501
Authors: Marta Guasch-Ferré; Frank B Hu; Miguel A Martínez-González; Montserrat Fitó; Mònica Bulló; Ramon Estruch; Emilio Ros; Dolores Corella; Javier Recondo; Enrique Gómez-Gracia; Miquel Fiol; José Lapetra; Lluís Serra-Majem; Miguel A Muñoz; Xavier Pintó; Rosa M Lamuela-Raventós; Josep Basora; Pilar Buil-Cosiales; José V Sorlí; Valentina Ruiz-Gutiérrez; J Alfredo Martínez; Jordi Salas-Salvadó Journal: BMC Med Date: 2014-05-13 Impact factor: 8.775
Authors: Chun Li; Xia Du; Yang Liu; Qi-Qi Liu; Wen Bing Zhi; Chun Liu Wang; Jie Zhou; Ye Li; Hong Zhang Journal: Evid Based Complement Alternat Med Date: 2020-01-08 Impact factor: 2.629
Authors: Heidi T M Lai; Marcia C de Oliveira Otto; Yujin Lee; Jason H Y Wu; Xiaoling Song; Irena B King; Bruce M Psaty; Rozenn N Lemaitre; Barbara McKnight; David S Siscovick; Dariush Mozaffarian Journal: J Am Heart Assoc Date: 2019-11-12 Impact factor: 5.501